TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
TLRY

Tilray Inc

Healthcare · Drug Manufacturers - Specialty & Generic

2.60$ +0.8% vs. previous close Closing price · As of: Nov 2, 2026

Statements

Income Statement

Tilray Inc (TLRY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q3 26), "Revenue" came in at 257 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement TLRY
Line item Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 LTM
262 256 313 200 211 186 225 210 218 207 282 257 963
198 189 201 140 150 134 157 152 160 152 197 180 689
64 67 112 60 61 52 68 57 57 55 84 78 274
0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.4
59 54 65 44 46 39 38 41 51 50 61 58 220
121 178 135 96 103 812 1,512 55 80 81 89 102 352
-57 -111 -23 -37 -42 -760 -1,444 2.1 -22 -26 -4.5 -24 -77
12 12 13 9.8 7.8 8.4 4.0 6.7 5.4 5.0 6.6 6.5 23
-67 -146 -59 -34 -83 -792 -1,393 -0.8 -40 -23 -24 -38 -126
-4.6 -3.9 -38 0.9 2.0 1.2 -125 -2.3 3.5 2.0 14 1.7 21
-66 -126 -43 -39 -85 -789 -1,273 -0.3 -45 -27 -50 -43 -164
-13 -90 15 7.9 -41 -750 -1,355 21 -19 -1.6 15 -13 -19

LTM = last twelve months (sum of the four most recent quarters).

Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?